Research

Metabolic adaptation

Laparoscopic Roux-en-Y gastric bypass provides superior long-term remission of dyslipidaemia, hypertension, and gastro-oesophageal reflux disease compared to laparoscopic sleeve gastrectomy.

Surgeons should consider Roux-en-Y gastric bypass for patients with specific comorbidities.

StrongSupportsmedium confidence
Laparoscopic Roux-en-Y gastric bypass provides superior long-term remission of dyslipidaemia, hypertension and gastro-oesophageal reflux disease compared to laparoscopic sleeve gastrectomy (SG).
Vidit Dholakia et al. · Journal of Minimal Access Surgery · 2026

Why this rating

Based on comparative effectiveness data from included studies.

Source

The evolving landscape of metabolic surgery: An evidence-based review

Vidit Dholakia et al. · Journal of Minimal Access Surgery · 2026

DOI 10.4103/jmas.jmas_551_25

Meta-analysis
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →